SLC16A1 and neoplasm: MCT1 blockade was shown to have anti‐angiogenic effects together with reduced tumor growth in a model of colon cancer xenograft involving the co‐injection of human umbilical vein endothelial cells HUVECs (Vegran, Boidot, Michiels, Sonveaux, & Feron, 2011).